To the Editor: Berlowitz et al. (Aug. 24 issue)1 reported scores on the Patient Health Questionnaire 9-item depression scale (PHQ-9) and the Veterans RAND 12-Item Health Survey (VR-12) that were similar between patients who received standard blood-pressure treatment and those who received intensive blood-pressure treatment, although they found significant differences in clinical outcomes.2 These findings could be due to poor sensitivity of the patient-reported outcome instruments used. In their trial, summary scoring was used in a population with a considerable ceiling effect for satisfaction with blood-pressure care, satisfaction with medication, and PHQ-9 and VR-12 scores at baseline.1 The ceiling effect . . .

中文翻译：

---

强化降压治疗和患者报告的结果

致编辑：Berlowitz等。（8月24日发行）1报告了在接受标准血压治疗的患者之间，患者健康问卷9项抑郁量表（PHQ-9）和退伍军人RAND 12项健康调查（VR-12）的得分相似以及接受强化血压治疗的患者，尽管他们发现临床结局存在显着差异。2这些发现可能是由于使用患者报告的结局工具敏感性差。在他们的试验中，汇总评分被用于对血压护理，药物满意度以及基线时的PHQ-9和VR-12得分具有较高上限效应的人群。1上限效应。。。